Stay Updated
Press Releases
10 Drug Corporations Drive One-Third of Taxpayer Spending in Medicare Part D
WASHINGTON, DC — Negotiating for the 250 most-expensive drugs in Medicare Part D would address nearly 80 percent of all spending in the program, according to an updated analysis by Patients For Affordable Drugs. The analysis, using data from CMS’ Medicare Part D Drug Spending Dashboard, found the top 250 drugs cost the program $118 Billion, […]
Press Releases
Vertex is pricing life-saving medicines out of reach.
To: Vertex Pharmaceuticals CEO Jeffrey Leiden We are members of cystic fibrosis, investment, and religious communities, and we agree that Vertex Pharmaceuticals, a Boston-based drug corporation, has priced life-saving drugs out of reach. It’s unfair. It’s unjust. And it must change. Cystic fibrosis is a rare genetic disease that impacts 70,000 to 100,000 people worldwide. […]
Press Releases
CHART PACK: New Analysis Shows Lion’s Share Of Part D Spending is For a Small Percentage of Drugs
WASHINGTON, DC — As Congress moves toward consideration of legislation to enable direct Medicare drug price negotiation, Patients For Affordable Drugs conducted an analysis to determine where the greatest savings could be achieved. The analysis, using data from CMS’ Medicare Part D Drug Spending Dashboard, shows that less than 1 percent of drugs accounts for […]
Press Releases
$2.1 Million Drug Marks Troubling Trend in Drug Pricing
WASHINGTON, DC — In response to the news that the FDA approved the Spinal Muscular Atrophy drug Zolgensma and Novartis set a $2,125,000 price tag, David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs, issued the following statement. STATEMENT: “Novartis is forcing families to answer one question: ‘What are you willing […]
Press Releases
NEW VIDEO TOOL: The Truth About GlaxoSmithKline
WASHINGTON, DC — On the heels of a new report that details how one of the world’s largest drug corporations is ripping off America, Patients For Affordable Drugs announced a new video tool to highlight how patients are hurt by GlaxoSmithKline’s sky-high prices. The new platform gives patients on GSK’s drugs the ability to seamlessly […]
Press Releases
NEW REPORT: The Truth About GlaxoSmithKline
WASHINGTON, DC – As Congress this week mulls a slate of reforms to curtail some of Big Pharma’s abusive pricing practices, Patients For Affordable Drugs released a new report that exposes how one of the world’s largest drug corporations is ripping off America. GlaxoSmithKline is the leading maker of blockbuster drugs to treat asthma, lupus, […]
Press Releases
“We are dying”: Patient to Share Drug Pricing Testimony at Energy & Commerce Hearing Today
WASHINGTON, D.C. — Over the 47 years Patient Advocate Gail deVore has lived with Type 1 diabetes, the price of her insulin has increased from $5 to $1,400 for four vials. Today, the Colorado resident will share her story during an Energy and Commerce Subcommittee hearing on the price of insulin. Almost 30 million Americans […]
Press Releases
FIRDAPSE FLOP: BIO Ignores Calls to Disavow Catalyst Pharmaceuticals
WASHINGTON, DC — One of Big Pharma’s major trade organizations has ignored a call from patients to expel Catalyst Pharmaceuticals — the drug maker responsible for increasing the price of an old drug from $0 to $375,000 overnight. Patients For Affordable Drugs sent a letter and a petition with nearly 2,000 signatures last week to Jim […]